Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalin.

Abstract

OBJECTIVE To evaluate the safety, tolerability, and efficacy of adding milnacipran to pregabalin in patients with fibromyalgia who have experienced an incomplete response to pregabalin. METHODS In this randomized, multicenter, open-label study, patients received pregabalin 300 or 450 mg/day during a 4- to 12-week run-in period. Patients with weekly recall… (More)
DOI: 10.1177/1759720X13483894

Topics

8 Figures and Tables

Cite this paper

@article{Mease2013MilnacipranCW, title={Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalin.}, author={Philip J Mease and Mildred V Farmer and Robert W. H. Palmer and R Michael Gendreau and Joel M. Trugman and Yong Wang}, journal={Therapeutic advances in musculoskeletal disease}, year={2013}, volume={5 3}, pages={113-26} }